You are here

Tiffany Hamm, Ph.D.

Director of International HIV Prevention and Treatment

Dr. Tiffany E. Hamm is the Director for the Global Health Programs (GHP) accountable for the execution of the President’s Emergency Plan for AIDS Relief (PEPFAR) and President’s Malaria Initiative (PMI) for the U.S. Military HIV Research Program (MHRP). Since 2003, Dr. Hamm has served as the primary lead for MHRP’s execution of the Army’s portion of PEPFAR under the oversight of the Office of the Global AIDS Coordinator (OGAC). In addition to direct responsibilities within MHRP, she also serves as MHRP PEPFAR liaison with USAID, CDC, HRSA and other USG agencies. She currently participates on several multi-agency groups including OGAC’s newly designed Care and Treatment Technical Working Group. In this capacity, she recently served as co-editor on a JAIDS manuscript covering a literature review of the impact of HIV care interventions and served as co-author on three of the articles. 

Dr. Hamm’s primary function is to oversee the implementation of large-scale, comprehensive care and treatment programs to include provision of antiretrovirals (ARV) for all MHRP Africa research sites in Kenya, Nigeria, Tanzania, Uganda and their surrounding communities. She also tracks implementation of work in lab development for the Vietnam Military. These programs encompass behavioral and clinical prevention interventions, HIV counseling and testing, ARV treatment, support networks for HIV-infected individuals and their families, and palliative care. Duties include directly managing a funding portfolio of over $70M/year and site-specific collaborations, which include local hospitals and community groups, as well as local and national non-governmental organizations (NGOs).

With the increased emphasis on transparency, accountability and impact under PEPFAR, Dr. Hamm has orchestrated recent changes within the GHP to improve the office’s ability to manage, monitor and research impact of the program. This includes working with leading MHRP clinical and therapeutics researchers in identifying areas for collaborative studies. Through key new staff hires and realignment of existing personnel, the GHP and its sites are placing more emphasis on areas of quality and effectiveness of interventions.

Prior to working with MHRP, Dr. Hamm worked in international development for three years as a Peace Corps Volunteer in the Solomon Islands as head of the science department of the Pawa Secondary School and then in the Kingdom of Tonga as a program manager for an NGO focusing on women’s development. Her early career in research focused on SIV studies in primates as an in vivo model for HIV replication and vaccine development under the direction of Dr. Phillip R. Johnson and Dr. Vanessa M. Hirsch. Following this work, Dr. Hamm researched mutational pressures of gene therapy approaches on HIV replication as a graduate student studying under Drs. Marie-Louise Hammarskjöld and David Rekosh.

Dr. Hamm is a graduate of Mary Baldwin College with a Bachelor of Arts in chemistry, and holds a doctorate in microbiology from the University of Virginia. She has over 10 years of research experience studying HIV vaccine development, HIV replication and RNA transport and over 16 years of experience in international development and program management.